NewsBenzingaIovance Biotherapeutics 第三季度每股收益(EPS)为$(0.05),好于预期$(0.09);销售额为1.21469亿美元,好于预期1.15982亿美元。 Iovance Biotherapeutics 第三季度每股收益(EPS)为$(0.05),好于预期$(0.09);销售额为1.21469亿美元,好于预期1.15982亿美元。 Benzinga 2026.11.05 12:09 (GMT+0) Open on Benzinga Other news Why Is Salesforce Stock Falling on Wednesday? This Elevance Health Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday Ford Ships First Battery Cells from Michigan Plant for Fathom Electric Pickup; Key Milestone for Ford Energy Bill Ackman Says Believes Board Not Acting In Best Interest Of Shareholders Nor In A Manner Consistent With Their Fiduciary Duties; Should Have Slept On Decision To Replace Jensen Huang And Met Again The Day After To Discuss The Facts Crude Oil Down Over 4%; Target Earnings Top Views BellRing Brands Beats Q4 Revenue Estimates, Announces New CFO
Ford Ships First Battery Cells from Michigan Plant for Fathom Electric Pickup; Key Milestone for Ford Energy
Bill Ackman Says Believes Board Not Acting In Best Interest Of Shareholders Nor In A Manner Consistent With Their Fiduciary Duties; Should Have Slept On Decision To Replace Jensen Huang And Met Again The Day After To Discuss The Facts